My baby's bruise was dismissed as a birthmark only for a tumour to engulf her face – I want to warn all parents
What began in November 2024 as a flat, pale blemish about an inch wide soon started to protrude, eventually pushing the little girl's ear out by two to three inches and engulfing her tiny face.
7
7
7
The mum-of-three said she "knew something was wrong" as her daughter cried non-stop and refused to feed, but was reassured by doctors it was nothing to worry about.
'We would never have expected it to turn out like this," the 29-year-old from Accrington, Lancashire, said.
"It literally just looked like a little bruise next to her ear.'
Brontë, now eight months old, was eventually diagnosed with kaposiform hemangioendothelioma (KHE) – a rare, aggressive vascular tumour.
The baby girl spent six weeks in hospital and has since developed Kasabach-Merritt phenomenon (KMP), a life-threatening condition that stops her blood from clotting.
'This tumour is benign, it's not cancerous, but she still might need chemotherapy," Natalie added.
"It can be life-threatening if it's not managed.'
She first noticed the blemish when Brontë was just two weeks old.
'From about two weeks of age it appeared and it was just a little bruise and as the weeks went on, we noticed that it never actually went,' she said.
'It was flat and very light in colour. Slowly over the months it started to get slightly bigger.
'We went to the doctors and they just confirmed it was a birthmark so we came away and carried on.'
But by January, the lump was darker, hotter, and growing fast.
'It started to get darker and started to protrude out and get quite big,' said Natalie.
'Since the day she was born she was hysterical nearly every day. There was nothing we could do to calm her down.
"I know every baby cries but this was just relentless. She wouldn't stop crying for about three or four hours non-stop.
'She'd refuse her feed and never finish a full bottle. She was awake every hour through the night. She was very restless and I never got a break.
7
7
'I knew something wasn't right but I didn't know what.'
After pushing for tests, Natalie was told Brontë would need an MRI in five weeks.
By May, the mark was growing so quickly that Natalie took Brontë to hospital herself.
There, an MRI was done, and the tumour was finally diagnosed.
'My family were saying I couldn't leave it that long as it was getting so aggressive,' she said.
'It was very hot to touch. It was very purple and looked angry. It was swollen and it was protruding and pushing her ear out.
"It was behind her ear in a full circle.'
Doctors told her the tumour would have been 'excruciatingly painful'.
'[The diagnosis] was shocking. It's flipped our world upside down to be honest. It's crazy because it's super rare.
'You never think becoming a parent of having this in your lifetime.
"You never imagine being in the hospital for a long time and having a poorly baby.'
On medication for life
Brontë was discharged after six weeks, but just ten days later Natalie spotted it growing again.
Tests confirmed her daughter now had KMP and her medication wasn't working.
'They can reverse that with medications but the tumour that she has gives her body really low platelet levels so her blood actually can't clot,' Natalie explained.
'It can now because she's had transfusions… but we were also informed that this tumour will never actually go.
'It's just managed by medication – and they can't tell us how long she will be on it for, it could potentially be for life.'
Natalie has set up a GoFundMe to help support the family as her maternity pay ends soon and she can't return to work in September.
What is KHE?
Kaposiform hemangioendothelioma (KHE) is a very rare tumour that forms from blood vessels, usually in babies and young children.
It's not cancer, but it can still be aggressive, painful, and dangerous.
The tumour typically appears in the skin, deep tissue or muscle and can cause swelling, redness and discomfort.
What causes it?
Doctors don't know exactly why KHE happens. It's not inherited and isn't caused by anything the parents did.
It's believed to be a random overgrowth of abnormal blood vessel cells, often starting shortly after birth.
What are the risks?
Around 70% of cases can lead to a serious complication called Kasabach-Merritt phenomenon (KMP).
This causes a big drop in platelets, meaning the blood can't clot properly — which can be life-threatening if not treated.
How is it treated?
Children with KHE are usually treated with:
Steroids
Drugs like sirolimus to shrink the tumour
Blood transfusions if platelet levels drop
Chemotherapy in some severe cases
In the UK, specialist centres like Great Ormond Street Hospital manage most cases.
How rare is it?
KHE is extremely rare - affecting around 1 in every 100,000 children.
'It takes the stress away as my maternity pay ends in a couple of weeks.
'Trust your instincts'
I was due back at work in September and Brontë was meant to start nursery,' she said.
'Although it can't take the pressure of her illness away, it can take the pressure of the financial struggle.
'Brontë deserves some really nice days out when she's stable so it gives us the chance to do that as well.'
The mum now urges other parents to speak up if something doesn't feel right.
'Trust your instincts. Even if you're wrong and you go to the doctors and it's nothing it doesn't matter," she said.
"You're not going to get told off. Just go and get it checked out as there is no wrong in doing that.
'You have your motherly instincts for a reason and I'm a firm believer that instincts don't lie.'
7
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
30 minutes ago
- Daily Mail
A new injection could REVERSE hearing loss and allow thousands to ditch their hearing aids. This is everything you need to know about it
For some two million people in the UK, hearing aids are a vital lifeline, allowing them to stay in touch with the world around them. But they cannot restore hearing – the devices work by amplifying sounds – and despite modern, sleek designs, for many people there is still a stigma attached to wearing them.
Daily Mail
3 hours ago
- Daily Mail
Zapping the brain with a tiny device on the ear could boost fitness without people having to lift a finger, study claims
A small device that zaps a major nerve connecting the heart and brain could one day help improve fitness for coach potatoes and people with heart failure, an early trial suggests. Wearing the stimulator for just 30 minutes a day increased oxygen intake during exercise by four per cent, according to researchers - who hope it could eventually be used to help more inactive people. The device, clipped to the outer ear, sends gentle electrical pulses to increase the activity of the vagus nerve, which plays a key role in regulating heart function. Led by researchers at University College London and Queen Mary University of London, the study involved 28 healthy volunteers. Half were given the nerve stimulator to wear for 30 minutes every day for a week, while the other half were given a dummy device. Following a two-week break, the groups swapped devices. All of those taking part in the trial had an exercise test at the beginning and end of the week they wore the stimulator. The trial, published in the European Heart Journal, found the 'dysfuntion' of the vagus nerve is 'strongly associated with impaired exercise tolerance'. Put simply: those wearing the nerve stimulator were able to exercise more intensely than when wearing the dummy device. After a week, the stimulator increased oxygen intake during exercise by 4%. It also boosted maximum breathing rate by an average of four breaths per minute, and maximum heart rate by four beats per minute during exercise. Gareth Ackland, a professor of perioperative medicine at Queen Mary University of London School of Medicine, said: 'Maintaining physical activity is essential for every aspect of cardiovascular, emotional, and cognitive health. 'The outcome of the trial is consistent with the significant body of evidence pointing to an important role of the brain in optimising exercise performance and regulating the activity of the immune system, helped by the vagus nerve'. Blood samples were also take from five people, with researchers suggesting wearing the nerve stimulator for a week helped reduce inflammation. Prof Ackland added: 'We will need to carry out larger trials to confirm our findings, but the results of this study in healthy volunteers suggest that increasing vagus nerve activity can improve fitness and reduce inflammation, potentially offering new approaches to improve heart health.' Professor Bryan Williams, chief scientific and medical officer at the British Heart Foundation, which funded the study, said: 'This early study suggests that a simple technology, which harnesses the connection between the heart and the brain, can lead to improvements in fitness and exercise tolerance. 'While more research is needed involving people with cardiovascular disease, this could one day be used as a tool to improve wellbeing and quality of life for people with heart failure.'
The Independent
4 hours ago
- The Independent
DIY cervical cancer tests most likely to be used if offered by GPs
DIY cervical cancer tests are more likely to be used if they are offered by a GP during a routine appointment, a study suggests. From January next year, at-home kits will be offered to women who have rarely or have never attended their cervical screening. The tests, which can be performed at home, look for the human papillomavirus (HPV) – the virus which is linked to the majority of cases of cervical cancer. A new study examined the most effective ways women can be approached about performing the tests themselves at home. Researchers from Queen Mary University of London and King's College London performed a study across 13 GP surgeries in west London. They found that under-screened women were more likely to take up the offer of a self-sample test if they were 'opportunistically' approached when they were visiting a GP for another reason. Fewer tests were returned when under-screened women were sent a test in the post, or were sent a letter inviting them to get a self-sampling kit. Of 449 women opportunistically offered a self-sample kit, 333 (74%) accepted the offer and 234 (52%) returned a sample within six months. Meanwhile, 198 of the 1,616 women sent a kit in the post (12%) and 76 of the 1,587 women sent a letter inviting them to order a kit (5%) returned a self-sample within six months. 'We showed that the uptake of self-sampling was by far the highest among women who were opportunistically offered kits in primary care,' the researchers wrote in the journal eClinicalMedicine. But the researchers said that more work was needed to ensure women who took up the offer returned their sample. 'Substantial numbers accepted (an opportunistic offer) or ordered (sent a letter) a kit but did not return a sample and over a quarter of those whose self-sample was HPV positive did not follow through with a clinician sample,' the authors added. They suggested that text or phone reminders 'could be valuable'. Senior researcher, Professor Peter Sasieni from Queen Mary University of London, said: 'Our study showed that offering a self-sample kit in person was the most effective method of encouraging women to complete their cervical cancer screening tests. But he said that a 'combination of approaches may be best for enabling more women to participate in cervical screening'. The NHS offers cervical screening tests – previously known as smear tests – to all women aged 25-64 every three years. But many people do not take up the offer, with a number citing a lack of time, discomfort or embarrassment. Data published by the NHS last November showed five million women are not up to date with routine check-ups.
